{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:40:57Z","timestamp":1789504857780,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2024J01043"],"award-info":[{"award-number":["2024J01043"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2022J01051"],"award-info":[{"award-number":["2022J01051"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["JCYJ20230807091204009"],"award-info":[{"award-number":["JCYJ20230807091204009"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008865","name":"Xiamen University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32270638"],"award-info":[{"award-number":["32270638"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32100464"],"award-info":[{"award-number":["32100464"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bioorg.2025.109113","type":"journal-article","created":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T22:36:40Z","timestamp":1760827000000},"page":"109113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Design, synthesis, and evaluation of 5-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)-1H-indole-2-carboxamide derivatives as anti-HCC agents targeting Nur77"],"prefix":"10.1016","volume":"167","author":[{"given":"Shengwei","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodan","family":"li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyue","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haofan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meijuan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinzhang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bioorg.2025.109113_bb0005","first-page":"47","article-title":"Cancer incidence and mortality in China, 2022","volume":"4","author":"Han","year":"2024","journal-title":"J. Natl. Cancer Cent."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109113_bb0010","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bioorg.2025.109113_bb0015","doi-asserted-by":"crossref","unstructured":"Sch\u00fctte, K., J. Bornschein, and P. Malfertheiner, Hepatocellular carcinoma--epidemiological trends and risk factors. Dig. Dis., 2009. 27(2): p. 80\u201392.","DOI":"10.1159\/000218339"},{"issue":"10127","key":"10.1016\/j.bioorg.2025.109113_bb0020","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet"},{"issue":"Suppl. 5","key":"10.1016\/j.bioorg.2025.109113_bb0025","doi-asserted-by":"crossref","first-page":"v59","DOI":"10.1093\/annonc\/mdq166","article-title":"Hepatocellular carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"21","author":"Jelic","year":"2010","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109113_bb0030","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.annonc.2019.12.001","article-title":"Pan-Asian adapted ESMO clinical practice guidelines for the management of patients with intermediate and advanced\/relapsed hepatocellular carcinoma: a TOS-ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO","volume":"31","author":"Chen","year":"2020","journal-title":"MOS and SSO. Ann Oncol"},{"issue":"15","key":"10.1016\/j.bioorg.2025.109113_bb0035","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1200\/JCO.23.02745","article-title":"Systemic therapy for advanced hepatocellular carcinoma: ASCO guideline update","volume":"42","author":"Gordan","year":"2024","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109113_bb0040","doi-asserted-by":"crossref","first-page":"302","DOI":"10.6004\/jnccn.2019.0019","article-title":"Guidelines insights: hepatobiliary cancers, version 2.2019","volume":"17","author":"Benson","year":"2019","journal-title":"J. Natl. Compr. Canc. Netw."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109113_bb0045","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109113_bb0050","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41392-020-0187-x","article-title":"The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects","volume":"5","author":"Tang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bioorg.2025.109113_bb0055","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.canlet.2019.12.002","article-title":"Immunotherapy for hepatocellular carcinoma","volume":"470","author":"Zongyi","year":"2020","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109113_bb0060","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s12967-022-03409-4","article-title":"Transcriptomic datasets of cancer patients treated with immune-checkpoint inhibitors: a systematic review","volume":"20","author":"Kov\u00e1cs","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bioorg.2025.109113_bb0065","article-title":"Immunotherapy-associated pancreatic adverse events: current understanding of their mechanism, diagnosis, and management","volume":"11","author":"Liu","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bioorg.2025.109113_bb0070","doi-asserted-by":"crossref","first-page":"11725","DOI":"10.2147\/OTT.S279858","article-title":"Adverse effects of immune-checkpoint inhibitors in hepatocellular carcinoma","volume":"13","author":"Cui","year":"2020","journal-title":"Onco. Targets. Ther."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109113_bb0075","doi-asserted-by":"crossref","first-page":"2247303","DOI":"10.1080\/2162402X.2023.2247303","article-title":"Melanoma patients with immune-related adverse events after immune checkpoint inhibitors are characterized by a distinct immunological phenotype of circulating T cells and M-MDSCs","volume":"12","author":"Lepper","year":"2023","journal-title":"Oncoimmunology"},{"issue":"6","key":"10.1016\/j.bioorg.2025.109113_bb0080","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1517\/14728222.2012.680958","article-title":"Nur77: a potential therapeutic target in cancer","volume":"16","author":"To, S.K","year":"2012","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.bioorg.2025.109113_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112608","article-title":"Design, synthesis, and biological evaluation of 5-((8-methoxy-2-methylquinolin-4-yl)amino)-1H-indole-2-carbohydrazide derivatives as novel Nur77 modulators","volume":"204","author":"Li","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2025.109113_bb0090","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nchembio.106","article-title":"Cytosporone B is an agonist for nuclear orphan receptor Nur77","volume":"4","author":"Zhan","year":"2008","journal-title":"Nat. Chem. Biol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109113_bb0095","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.molcel.2017.03.008","article-title":"Celastrol-induced Nur77 interaction with TRAF2 alleviates inflammation by promoting mitochondrial ubiquitination and autophagy","volume":"66","author":"Hu","year":"2017","journal-title":"Mol. Cell"},{"issue":"11","key":"10.1016\/j.bioorg.2025.109113_bb0100","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/nchembio.1069","article-title":"The orphan nuclear receptor Nur77 regulates LKB1 localization and activates AMPK","volume":"8","author":"Zhan","year":"2012","journal-title":"Nat. Chem. Biol."},{"issue":"41","key":"10.1016\/j.bioorg.2025.109113_bb0105","doi-asserted-by":"crossref","first-page":"69731","DOI":"10.18632\/oncotarget.19227","article-title":"Modulation of the Nur77-Bcl-2 apoptotic pathway by p38\u03b1 MAPK","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"issue":"5482","key":"10.1016\/j.bioorg.2025.109113_bb0110","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1126\/science.289.5482.1159","article-title":"Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3","volume":"289","author":"Li","year":"2000","journal-title":"Science"},{"issue":"13","key":"10.1016\/j.bioorg.2025.109113_bb0115","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1016\/j.yexcr.2007.04.032","article-title":"Involvement of TR3\/Nur77 translocation to the endoplasmic reticulum in ER stress-induced apoptosis","volume":"313","author":"Liang","year":"2007","journal-title":"Exp. Cell Res."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109113_bb0120","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ccr.2008.09.002","article-title":"A short Nur77-derived peptide converts Bcl-2 from a protector to a killer","volume":"14","author":"Kolluri","year":"2008","journal-title":"Cancer Cell"},{"issue":"23","key":"10.1016\/j.bioorg.2025.109113_bb0125","doi-asserted-by":"crossref","first-page":"15847","DOI":"10.1021\/acs.jmedchem.3c01336","article-title":"Discovery of 5-(Pyrimidin-2-ylamino)-1H-indole-2-carboxamide derivatives as Nur77 modulators with selective and potent activity against triple-negative breast Cancer","volume":"66","author":"Qin","year":"2023","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2025.109113_bb0130","doi-asserted-by":"crossref","first-page":"5493","DOI":"10.1016\/j.apsb.2024.07.012","article-title":"Discovery of a novel exceptionally potent and orally active Nur77 ligand NB1 with a distinct binding mode for cancer therapy","volume":"14","author":"Chen","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bioorg.2025.109113_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105651","article-title":"Discovery of a Nur77-mediated cytoplasmic vacuolation and paraptosis inducer (4-PQBH) for the treatment of hepatocellular carcinoma","volume":"121","author":"Li","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109113_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114849","article-title":"Discovery of 5-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)-1H-indole-2-carboxamide derivatives as novel anti-cancer agents targeting Nur77","volume":"244","author":"Qin","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109113_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.108113","article-title":"Design, synthesis, and biological evaluation of N(1)-(2-(adamantan-1-yl)-1H-indol-5-yl)-N(2)-(substituent)-1,2-dicarboxamides as anticancer agents targeting Nur77-mediated endoplasmic reticulum stress","volume":"155","author":"Hu","year":"2025","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109113_bb0150","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41392-020-0134-x","article-title":"Molecular principles of metastasis: a hallmark of cancer revisited","volume":"5","author":"Fares","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"10","key":"10.1016\/j.bioorg.2025.109113_bb0155","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.tcb.2020.07.003","article-title":"EMT, MET, plasticity, and tumor metastasis","volume":"30","author":"Bakir","year":"2020","journal-title":"Trends Cell Biol."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109113_bb0160","first-page":"4793","article-title":"Characteristics of Nur77 and its ligands as potential anticancer compounds (review)","volume":"18","author":"Wu","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"19","key":"10.1016\/j.bioorg.2025.109113_bb0165","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1016\/j.molcel.2021.09.016","article-title":"NR4A1 regulates expression of immediate early genes, suppressing replication stress in cancer","volume":"81","author":"Guo","year":"2021","journal-title":"Mol. Cell"},{"issue":"3","key":"10.1016\/j.bioorg.2025.109113_bb0170","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nchembio.304","article-title":"Inhibition of eukaryotic translation elongation by cycloheximide and lactimidomycin","volume":"6","author":"Schneider-Poetsch","year":"2010","journal-title":"Nat. Chem. Biol."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109113_bb0175","doi-asserted-by":"crossref","first-page":"583","DOI":"10.20892\/j.issn.2095-3941.2020.0066","article-title":"Proteasomal and lysosomal degradation for specific and durable suppression of immunotherapeutic targets","volume":"17","author":"Wang","year":"2020","journal-title":"Cancer Biol. Med."},{"issue":"8","key":"10.1016\/j.bioorg.2025.109113_bb0180","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1080\/15548627.2018.1474314","article-title":"Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion","volume":"14","author":"Mauthe","year":"2018","journal-title":"Autophagy"},{"issue":"11","key":"10.1016\/j.bioorg.2025.109113_bb0185","doi-asserted-by":"crossref","DOI":"10.3390\/biom10111507","article-title":"Proteasome inhibitor MG132 is toxic and inhibits the proliferation of rat neural stem cells but increases BDNF expression to protect neurons","volume":"10","author":"Kim","year":"2020","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109113_bb0190","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s004410000193","article-title":"The morphology of apoptosis","volume":"301","author":"H\u00e4cker","year":"2000","journal-title":"Cell Tissue Res."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109113_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0286903","article-title":"The angiotensin receptor neprilysin inhibitor LCZ696 attenuates renal fibrosis via ASK1\/JNK\/p38 MAPK-mediated apoptosis in unilateral ureteral obstruction","volume":"18","author":"Ding","year":"2023","journal-title":"PLoS One"},{"issue":"7\u20139","key":"10.1016\/j.bioorg.2025.109113_bb0200","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1089\/ars.2021.0083","article-title":"PDK4 decrease neuronal apoptosis via inhibiting ROS-ASK1\/P38 pathway in early brain injury after subarachnoid Hemorrhage","volume":"36","author":"Gao","year":"2022","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bioorg.2025.109113_bb0205","doi-asserted-by":"crossref","unstructured":"Hu, H., et al., Design, synthesis and biological evaluation of methylenehydrazine-1-carboxamide derivatives with (5-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)-1H-indole scaffold: novel potential CDK9 inhibitors. Bioorg. Chem., 2020. 102: p. 104064.","DOI":"10.1016\/j.bioorg.2020.104064"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825009939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825009939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T14:00:39Z","timestamp":1773324039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825009939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":41,"alternative-id":["S0045206825009939"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109113","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and evaluation of 5-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)-1H-indole-2-carboxamide derivatives as anti-HCC agents targeting Nur77","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109113","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109113"}}